IBA Molecular, a global leader in the manufacture and distribution of radiopharmaceuticals, announced today the completion of the previously announced sale of its US operations, IBA Molecular North America, Inc. (IBAM NA), to Illinois Health and Science (IHS), a non-profit healthcare system based in Decatur, Illinois. 

Emergency physicians increasingly turn to intravenous, contrast-enhanced abdominal CT even when they’re quite sure from symptom presentation alone that the patient has acute appendicitis. 

Republican Congresswoman Renee Ellmers of North Carolina has joined with Democrat Debbie Wasserman Schultz of Florida to try to hold the tide against the breast-cancer screening recommendations drafted by the U.S. Preventive Service Task Force (USPSTF) this past spring.

Shimadzu Medical Systems USA announces the availability of T-smart, a new tomographic image reconstruction function using iterative reconstruction that improves the clarity of tomosynthesis-acquired orthopedic images containing metal implanted objects such as used in orthopedics.

When it comes to reducing the number of deaths caused by breast cancer, starting screening mammography at age 40 and continuing it yearly does the job and does it well for at least 10 years after the initial exam. 

Radiology personnel at two large academic hospitals hewed to the Joint Commission’s mandated “dual-identifier” technique to avoid misidentifying patients and/or wrongly dictating reports—but still created a number of near-miss patient events.

The potential for PET-based amyloid imaging to advance care of Alzheimer’s patients has excited many in the field of neuroimaging for years, yet the role of such scans has been difficult to define.

There is a new Imaging Dementia–Evidence for Amyloid Scanning Study (IDEAS) website that aims to enable patients, caregivers, providers and PET facilities to get up-to-date study information, learn how to get involved and receive updates on enrollment timelines and pathways.